CIK: 1527134 - Address: C/o Aegerion Pharmaceuticals, Inc., One Main Street, Suite 800, Cambridge, MA 02142
32 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1116-2-11-9-28-56-16
S%wins75566975819475

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/18/14 16:01
3/14/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D23944-40-17-6-1885-5-19-24-39-43-51
3/18/14 16:01
3/14/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-10351.3433-2-1000D23944-40-17-6-1885-5-19-24-39-43-51
2/18/14 16:05
2/14/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D270118-28-23-14118-5-37-14-51-54-61
2/18/14 16:05
2/14/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-12763.4933-2-1000D270118-28-23-14118-5-37-14-51-54-61
1/21/14 16:01
1/16/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D315133-21-27-8-10-153-1-90-29-56-59
1/21/14 16:01
1/16/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-11758.6333-2-1000D315133-21-27-8-10-153-1-90-29-56-59
1/6/14 16:01
1/2/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d1313.013310D3391713-231413620-4-14-36-51-62
1/6/14 16:01
1/2/14
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-7170.9333-1-1000D3391713-231413620-4-14-36-51-62
12/17/13 16:06
12/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D3012004-24-21-4-2407-8-20-46-68
12/17/13 16:06
12/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-13366.3433-2-1000D3012004-24-21-4-2407-8-20-46-68
12/4/13 17:01
12/2/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d3913.013330D327217-6-27-19-160-4-2-46-28-53-70
12/4/13 17:01
12/2/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-21170.4233-3-1000D327217-6-27-19-160-4-2-46-28-53-70
11/19/13 17:00
11/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D3342239-23-23-30-8-21-25-1-1-52-69
11/19/13 17:00
11/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-15276.0933-2-1000D3342239-23-23-30-8-21-25-1-1-52-69
11/5/13 16:00
11/1/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d4613.013340D54128294-906-7-2-9-1-16-29-58-74
11/5/13 16:00
11/1/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-29183.2833-4-1000D54128294-906-7-2-9-1-16-29-58-74
10/16/13 17:04
10/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D466464102-2-16-7-19-621-2-31-51-67
10/16/13 17:04
10/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-16180.3333-2-1000D466464102-2-16-7-19-621-2-31-51-67
10/8/13 17:15
10/7/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d4613.013340D58352113830179-3-10-5-2-17-47-55
10/8/13 17:15
10/7/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-32693.1733-4-1000D58352113830179-3-10-5-2-17-47-55
9/18/13 16:05
9/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D48245412636-60-5-54-1-1-21-37-58
9/18/13 16:05
9/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-18089.7733-2-1000D48245412636-60-5-54-1-1-21-37-58
8/20/13 17:06
8/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D50950119844224-5-648-1-11-26-62
8/20/13 17:06
8/16/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-17788.7133-2-1000D50950119844224-5-648-1-11-26-62
7/16/13 17:00
7/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d2613.013320D419441189103936161241236-20-62
7/16/13 17:00
7/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-15878.7733-2-1000D419441189103936161241236-20-62
6/19/13 16:00
6/17/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d7813.013360D2773331886648-8-14-8-1-326396-43
6/19/13 16:00
6/17/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-39265.2733-6-1000D2773331886648-8-14-8-1-326396-43
5/17/13 16:30
5/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d7813.013360D18234719311460644434-2-114233-48
5/17/13 16:30
5/15/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-28447.3233-6-1000D18234719311460644434-2-114233-48
4/24/13 14:23
4/22/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeM.d7813.012060D1492431124710622-5343881038
4/24/13 14:23
4/22/13
AEGRAegerion Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSumeray MarkMAOChief MeS.d-24440.7420-6-1000D1492431124710622-5343881038

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact